Recent studies investigating follow-up strategies for colorectal cancer (CRC) patients after treatment have provided favourable evidence for more intensive follow-up protocols using the measurement of serum carcinoembryonic antigen (CEA). Here, CEACAM5 is linked to colorectal carcinoma.